Close Menu

NEW YORK (GenomeWeb) – Sengenics today announced it has acquired Oxford Gene Technology's protein array technology for an undisclosed amount. 

The technology, which will be rebranded Immunome, is an auto-antibody profiling platform developed as a joint collaboration between the University o fOxford and the University of Cambridge. It is the only array platform in which every protein is full length, correctly folded, and functionally validated, Sengenics said, adding that Immunome ensures that only correctly folded proteins are presented on the array. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.

Jun
06
Sponsored by
NRGene & Illumina

This webinar will discuss the impact of affordable de novo genome assemblies on crop research.

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect.